This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,787,389 units of 40 mg Vyvanse capsules. The contract has a potential value of $2,038.25 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under a larger indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of 100 units of the pharmaceutical drug Vyvanse (40 mg capsules). The total potential value of this order is $1,012.50, with a completion date of February 23, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,756,004 units of the prescription medication Vyvanse 30 mg capsules. The total potential value of the award is $1,997.00 with a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this contract. This...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,564,118,788 units of the pharmaceutical product Vyvanse 50 mg capsules. The total ceiling value of the contract is $10,020.09 with a performance period through April 1, 2024. This delivery order falls under a larger...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,563,606,240 units of Vyvanse 40 mg capsules, with a potential value of $3,138.50. The contract completion date is February 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $10,066.56, is for the delivery of 100 units of the pharmaceutical product Vyvanse 30 mg capsules. The delivery order has an ultimate completion date of April 1, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of global pharmaceutical distributor Amerisourcebergen Corporation. The $22,000.27 contract is for the supply of Vyvanse 30mg capsules, with a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which...
This is a $1,491.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 30 mg capsules. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Vyvanse 30 mg capsules. The contract has a completion date of March 8, 2024 and a potential value of $2,080.64. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,563,667,002 units of 20 mg Vyvanse capsules, with a potential value of $2,705.14 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not have a set-aside designation. This award is...